Skip to main content
. 2015 Sep 15;138(11):3373–3385. doi: 10.1093/brain/awv267

Figure 2.

Figure 2

Scatter plot showing the subjects included in the study classified as amyloid positive (+) or negative (−) based on a previously established cut-off (CSF amyloid-β42 < 192 pg/ml). The data are presented as medians and interquartile ranges. Differences between groups were assessed by linear regression, adjusted for age and sex. *P < 0.05; **P < 0.01; ***P < 0.001. Ng = neurogranin.